23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.79%
Negative revenue growth while Insurance - Life median is 0.97%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-5.79%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-28.18%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-28.18%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-33.49%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-33.48%
Negative EPS growth while Insurance - Life median is 1.19%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-33.48%
Negative diluted EPS growth while Insurance - Life median is 1.21%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.38%
OCF growth exceeding 1.5x Insurance - Life median of 15.20%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
38.38%
FCF growth exceeding 1.5x Insurance - Life median of 16.66%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
91.52%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 59.95%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
68.89%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 23.33%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
7.81%
3Y revenue/share growth below 50% of Insurance - Life median of 16.04%. Jim Chanos would suspect a significant short-term erosion in competitiveness.
74.52%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 43.08% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
105.23%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 26.13%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
26.86%
3Y OCF/share growth of 26.86% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-18.94%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 34.20%. Seth Klarman might see a fundamental problem if peers maintain growth.
53.96%
5Y net income/share CAGR > 1.5x Insurance - Life median of 20.65%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
108.71%
3Y net income/share CAGR > 1.5x Insurance - Life median of 64.80%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
76.57%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
61.09%
5Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might see disciplined retention of earnings behind outperformance.
16.88%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.16%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
1.25%
Asset growth 50-75% of Insurance - Life median. Guy Spier sees potential underinvestment or overcaution vs. peers.
1.87%
Below 50% of Insurance - Life median. Jim Chanos suspects deeper issues blocking net worth accumulation.
-1.16%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
5.16%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.